I. A. Hashmi et al. · One-pot, Three-component Synthesis of 7H-[1,3,4]Thiadiazolo[3,2-a]pyridines
1303
5 Harom., PhC=O). – 13C NMR (62.9 MHz, CDCl3): δ = 14.3 J = 8.4 Hz, 2 Harom., Ar1), 7.15 (d, J = 8.4 Hz, 2 Harom., Ar2),
(OCH2CH3), 15.7 (2-CH3), 38.9 (C-7), 59.5 (OCH2), 81.6 7.25 (d, J = 8.4 Hz, 2 Harom., Ar2). – 13C NMR (62.9 MHz,
(C-6), 104.6 (C-8), 148.1 (C-8a), 150.3 (C-2), 155.1 (C-5), CDCl3): δ = 15.6 (2-CH3), 21.1 (PhCH3), 40.9 (C-7), 64.3
126.8, 127.3, 128.1, 128.7, 130.0, 135.6, 139.4, 143.9 (total (C-6), 101.9 (C-8), 119.7 (CN), 146.7 (C-8a), 151.0 (C-2),
12 Carom.), 169.1 (6-C=O), 191.4 (8-C=O).
155.5 (C-5), 126.5 (2 C), 128.3 (2 C), 128.5 (2 C), 129.6
(2 C), 136.2, 136.9, 137.5, 142.2 (total 12 Carom.), 189.9
(8-C=O).
Ethyl 5-amino-8-benzoyl-2-methyl-7-(4-nitrophenyl)-7H-
[1,3,4]thiadiazolo[3,2-a]pyridine-6-carboxylate (5k)
5-Amino-8-(4-chlorobenzoyl)-2-methyl-7-(4-nitrophenyl)-
IR (ATR): ν = 3392 and 3287 (NH2), 1671 (C=O, ketone),
1620 (C=O, ester) cm−1. – 1H NMR (250 MHz, CDCl3): δ =
1.13 (t, J = 7.1 Hz, 3 H, OCH2CH3), 2.53 (s, 3 H, 2-CH3),
4.07 (q, J = 7.1 Hz, 2 H, OCH2), 5.43 (s, 1 H, 7-H), 6.85
(d, J = 8.7 Hz, 2 Harom.), 7.90 (d, J = 8.7 Hz, 2 Harom.),
6.7 – 8.0 (br., 2 H, NH2), 7.2 – 7.5 (m, 5 Harom., PhC=O). –
13C NMR (62.9 MHz, CDCl3): δ = 14.3 (OCH2CH3), 15.7
(2-CH3), 40.0 (C-7), 59.8 (OCH2), 80.4 (C-6), 103.2 (C-8),
148.0 (C-8a), 151.0 (C-2), 155.5 (C-5), 123.3 (2 C), 126.9
(2 C), 127.9 (2 C), 128.5 (2 C), 130.4, 139.2, 146.2, 153.9
(total 12 Carom.), 168.6 (6-C=O), 191.0 (8-C=O).
7H-[1,3,4]thiadiazolo[3,2-a]pyridine-6-carbonitrile (5o)
IR (ATR): ν = 3448 and 3338 (NH2), 2184 (CN), 1653
(C=O) cm−1. – 1H NMR (250 MHz, [D6]DMSO): δ = 2.55
(s, 3 H, 2-CH3), 5.05 (s, 1 H, 7-H), 7.05 (br. s, 2 H, NH2),
7.06 (d, J = 8.7 Hz, 2 Harom., Ar1), 7.25 (d, J = 8.4 Hz,
2 Harom., Ar2), 7.38 (d, J = 8.4 Hz, 2 Harom., Ar2), 8.04 (d, J =
8.7 Hz, 2 Harom., Ar1). – 13C NMR (62.9 MHz, [D6]DMSO):
δ = 15.1 (2-CH3), 41.2 (C-7), 60.3 (C-6), 100.0 (C-8), 119.6
(CN), 146.1 (C-8a), 152.6 (C-2), 155.1 (C-5), 123.8 (2 C),
127.8 (2 C), 128.2 (2 C), 128.4 (2 C), 134.6, 137.8, 146.1,
151.8 (total 12 Carom.), 188.2 (8-C=O).
5-Amino-8-(4-chlorobenzoyl)-2-methyl-7-phenyl-7H-
[1,3,4]thiadiazolo[3,2-a]pyridine-6-carbonitrile (5l)
5-Amino-2-methyl-8-(4-methylbenzoyl)-7-phenyl-7H-[1,3,4]
thiadiazolo[3,2-a]pyridine-6-carbonitrile (5p)
IR (ATR): ν = 3466 and 3314 (NH2), 2187 (CN), 1652
IR (ATR): ν = 3465 and 3314 (NH2), 2187 (CN), 1651
(C=O, ketone) cm−1. – 1H NMR (250 MHz, CDCl3): δ =
2.35 (s, 3 H, Ar1CH3), 2.49 (s, 3 H, 2-CH3), 4.92 (s, 1 H,
7-H), 5.20 (br. s, 2 H, NH2), 7.20 (mc, 9 Harom., Ar1 + Ar2). –
13C NMR (62.9 MHz, CDCl3): δ = 15.5 (2-CH3), 21.5
(Ar1CH3), 41.2 (C-7), 63.8 (C-6), 102.1 (C-8), 119.7 (CN),
147.0 (C-8a), 150.3 (C-2), 155.4 (C-5), 126.6, 127.0, 127.1,
128.7, 128.9, 136.1, 140.57, 145.1 (total 12 Carom.), 191.2
(8-C=O).
1
(C=O) cm−1. – H NMR (250 MHz, CDCl3): δ = 2.53 (s,
3 H, 2-CH3), 4.82 (s, 1 H, 7-H), 5.21 (br. s, 2 H, NH2),
6.86 (mc, 2 Harom., Ph), 7.13 (d, J = 8.6 Hz, 2 Harom., Ar1),
7.13 – 7.27 (m, 3 Harom., Ph), 7.27 (d, J = 8.6 Hz, 2 Harom.
,
Ar1). – 13C NMR (62.9 MHz, CDCl3): δ = 15.5 (2-CH3),
41.3 (C-7), 64.3 (C-6), 101.7 (C-8), 119.5 (CN), 151.0 (C-2),
155.5 (C-5), 146.6 (C-8a), 126.6, 127.3, 128.2, 128.5, 128.9,
136.2, 137.4, 144.9 (total 12 Carom.), 190.0 (8-C=O).
5-Amino-8-(4-chlorobenzoyl)-7-(4-chlorophenyl)-2-methyl-
7H-[1,3,4]thiadiazolo[3,2-a]pyridine-6-carbonitrile (5m)
5-Amino-8-(4-methoxybenzoyl)-2-methyl-7-phenyl-7H-
[1,3,4]thiadiazolo[3,2-a]pyridine-6-carbonitrile (5q)
IR (ATR): ν = 3459 and 3301 (NH2), 2193 (CN), 1657
IR (ATR): ν = 3463 and 3321 (NH2), 2187 (CN), 1657
(C=O, ketone) cm−1. – 1H NMR (500 MHz, CDCl3): δ =
2.47 (s, 3 H, 2-CH3), 3.81 (s, 3 H, OMe), 4.97 (s, 1 H,
7-H), 5.28 (s, 2 H, NH2), 6.82 (d, J = 8.5 Hz, 2 Harom.),
6.91 (d, J = 7.2 Hz, 2 Harom.), 7.19 (mc, 3 Harom.), 7.29 (d,
J = 8.5 Hz, 2 Harom.). – 13C NMR (125,8 MHz, CDCl3):
δ = 15.2 (2-CH3), 41.3 (C-7), 55.4 (OMe), 63.4 (C-6), 102.1
(C-8), 119.9 (CN), 147.2 (C-8a), 150.4 (C-2), 155.4 (C-5),
113.6 (2 C), 126.5 (2 C), 127.1, 128.8 (2 C), 129.0 (2 C),
131.3, 145.1, 161.3 (total 12 Carom.), 190.3 (8-C=O).
1
(C=O) cm−1. – H NMR (250 MHz, CDCl3): δ = 2.50 (s,
3 H, 2-CH3), 4.82 (s, 1 H, 7-H), 5.33 (br. s, 2 H, NH2), 6.77
(d, J = 8.4 Hz, 2 Harom., Ar1), 7.14 (d, J = 8.4 Hz, 4 Harom.
,
Ar1 + Ar2), 7.29 (d, J = 8.4 Hz, 2 Harom., Ar2). – 13C NMR
(62.9 MHz, CDCl3): δ = 15.5 (2-CH3), 40.9 (C-7), 63.7
(C-6), 101.4 (C-8), 119.3 (CN), 151.1 (C-2), 155.6 (C-5),
146.7 (C-8a), 128.0 (2 C), 128.1 (2 C), 128.6 (2 C), 128.9
(2 C), 133.1, 136.3, 137.3, 143.5 (total 12 Carom.), 189.8
(8-C=O).
5-Amino-8-(4-chlorobenzoyl)-2-methyl-7-(4-methylphenyl)-
5-Amino-8-(4-methoxybenzoyl)-2-methyl-7-(4-nitrophenyl)-
7H-thiadiazolo[3,2-a]pyridine-6-carbonitrile (5n)
7H-[1,3,4]thiadiazolo[3,2-a]pyridine-6-carbonitrile (5r)
IR (ATR): ν = 3457 and 3301 (NH2), 2194 (CN), 1651
IR (ATR): ν = 3464 and 3322 (NH2), 2186 (CN), 1659
1
1
(C=O) cm−1. – H NMR (250 MHz, CDCl3): δ = 2.25 (s, (C=O) cm−1. – H NMR (250 MHz, CDCl3): δ = 2.53 (s,
3 H, Ar2CH3), 2.48 (s, 3 H, 2-CH3), 4.77 (s, 1 H, 7-H), 5.28 3 H, 2-CH3), 3.84 (s, 3 H, OMe), 5.17 (s, 1 H, 7-H), 5.28
(br. s, 2 H, NH2), 6.74 (d, J = 8.4 Hz, 2 Harom., Ar1), 6.98 (d, (br. s, 2 H, NH2), 6.85 (d, J = 8.8 Hz, 2 H, Ar1), 7.03 (d,
Unauthenticated
Download Date | 11/24/15 7:40 AM